Show simple item record

dc.contributor.authorTenorio-Jiménez, Carmen
dc.contributor.authorMartínez Ramírez, María José
dc.contributor.authorGil Hernández, Ángel 
dc.contributor.authorGómez Llorente, Carolina
dc.date.accessioned2020-04-14T11:49:49Z
dc.date.available2020-04-14T11:49:49Z
dc.date.issued2020-01-01
dc.identifier.citationTenorio-Jiménez, C., Martínez-Ramírez, M. J., Gil, Á., & Gómez-Llorente, C. (2020). Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials. Nutrients, 12(1), 124.es_ES
dc.identifier.urihttp://hdl.handle.net/10481/61182
dc.description.abstractThe aim of this systematic review is to evaluate whether the use of probiotics has any effect on the components of metabolic syndrome (MetS) before patients develop type 2 diabetes. A qualitative systematic review, following the Cochrane methodology, and a comprehensive literature search of randomized controlled trials (RCTs) were conducted in PubMed and Scopus from inception until 4 July 2019. According to our inclusion criteria, nine clinical studies were finally analyzed, corresponding to six RCTs. Probiotics intake in patients with MetS resulted in improvements in body mass index, blood pressure, glucose metabolism, and lipid profile in some studies. Regarding inflammatory biomarkers, probiotics also positively affected the soluble vascular cell adhesion molecule 1 (sVCAM-1), interleukine-6 (IL-6), tumor necrosis factor alpha (TNF-alpha), vascular endothelial growth factor (VEGF), and thrombomodulin. Despite the diversity of the published studies, the intake of probiotics for patients with MetS may offer a discrete improvement in some of the clinical characteristics of the MetS and a decrease in inflammatory biomarkers. Nevertheless, these beneficial effects seem to be marginal compared to drug therapy and a healthy lifestyle and clinically non-relevant.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectMetabolic syndromees_ES
dc.subjectGastrointestinal microbiomees_ES
dc.subjectProbioticses_ES
dc.subjectObesity es_ES
dc.titleEffects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trialses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3390/nu12010124


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España